Phase I/II trial of autologous activated macrophages in advanced colorectal cancer
- 31 October 1996
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Cancer
- Vol. 32 (11), 1905-1911
- https://doi.org/10.1016/0959-8049(96)00233-x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1994
- Tumour-cytolytic human monocyte-derived macrophages: a simple and efficient method for the generation and long-term cultivation as non-adherent cells in a serum-free mediumResearch in Immunology, 1992
- Adoptive Immunotherapy with Activated Macrophages Grown In Vitro from Blood Monocytes in Cancer PatientsJournal of Immunotherapy, 1992
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancerCancer, 1992
- Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effectsCancer Immunology, Immunotherapy, 1991
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaThe New England Journal of Medicine, 1988
- Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered selfBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneThe New England Journal of Medicine, 1987